According to MEI Pharma latest financial reports the total liabilities of MEIP is $96.19M, an decrease of -23.31% to 2022. At the end of 2022 company had $125.43M total liabilities. This figure represents the company's financial obligations and debts, including loans, accounts payable, and other liabilities that MEI Pharma is responsible for during its operational activities.
Year | Total liabilities | Change |
---|---|---|
2023 | $96.19M | -23.31% |
2022 | $125.43M | 0.64% |
2021 | $124.63M | -6.06% |
2020 | $132.67M | 1261.80% |
2019 | $9.74M | - |